BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 26035084)

  • 1. Pharmacological interventions for drug-using offenders.
    Perry AE; Neilson M; Martyn-St James M; Glanville JM; Woodhouse R; Godfrey C; Hewitt C
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD010862. PubMed ID: 26035084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological interventions for drug-using offenders.
    Perry AE; Neilson M; Martyn-St James M; Glanville JM; McCool R; Duffy S; Godfrey C; Hewitt C
    Cochrane Database Syst Rev; 2013 Dec; (12):CD010862. PubMed ID: 24353217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for female drug-using offenders.
    Perry AE; Neilson M; Martyn-St James M; Glanville JM; Woodhouse R; Hewitt C
    Cochrane Database Syst Rev; 2015 Jun; (6):CD010910. PubMed ID: 26035085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for female drug-using offenders.
    Perry AE; Neilson M; Martyn-St James M; Glanville JM; McCool R; Duffy S; Godfrey C; Hewitt C
    Cochrane Database Syst Rev; 2014 Jan; (1):CD010910. PubMed ID: 24399765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions for female drug-using offenders.
    Perry AE; Martyn-St James M; Burns L; Hewitt C; Glanville JM; Aboaja A; Thakkar P; Santosh Kumar KM; Pearson C; Wright K
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD010910. PubMed ID: 31834635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance agonist treatments for opiate-dependent pregnant women.
    Minozzi S; Amato L; Jahanfar S; Bellisario C; Ferri M; Davoli M
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006318. PubMed ID: 33165953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions for drug-using offenders with co-occurring mental illness.
    Perry AE; Neilson M; Martyn-St James M; Glanville JM; McCool R; Duffy S; Godfrey C; Hewitt C
    Cochrane Database Syst Rev; 2014 Jan; (1):CD010901. PubMed ID: 24385324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions for drug-using offenders with co-occurring mental health problems.
    Perry AE; Martyn-St James M; Burns L; Hewitt C; Glanville JM; Aboaja A; Thakkar P; Santosh Kumar KM; Pearson C; Wright K; Swami S
    Cochrane Database Syst Rev; 2019 Oct; 10(10):CD010901. PubMed ID: 31588993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance agonist treatments for opiate-dependent pregnant women.
    Minozzi S; Amato L; Bellisario C; Ferri M; Davoli M
    Cochrane Database Syst Rev; 2013 Dec; (12):CD006318. PubMed ID: 24366859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for drug-using offenders with co-occurring mental illness.
    Perry AE; Neilson M; Martyn-St James M; Glanville JM; Woodhouse R; Godfrey C; Hewitt C
    Cochrane Database Syst Rev; 2015 Jun; (6):CD010901. PubMed ID: 26034938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological therapies for management of opium withdrawal.
    Rahimi-Movaghar A; Gholami J; Amato L; Hoseinie L; Yousefi-Nooraie R; Amin-Esmaeili M
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD007522. PubMed ID: 29929212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Breen C; Kimber J; Davoli M
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD002207. PubMed ID: 24500948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid agonist treatment for pharmaceutical opioid dependent people.
    Nielsen S; Larance B; Degenhardt L; Gowing L; Kehler C; Lintzeris N
    Cochrane Database Syst Rev; 2016 May; (5):CD011117. PubMed ID: 27157143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance treatments for opiate -dependent adolescents.
    Minozzi S; Amato L; Bellisario C; Davoli M
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD007210. PubMed ID: 24957634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buprenorphine for managing opioid withdrawal.
    Gowing L; Ali R; White JM; Mbewe D
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD002025. PubMed ID: 28220474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial interventions for benzodiazepine harmful use, abuse or dependence.
    Darker CD; Sweeney BP; Barry JM; Farrell MF; Donnelly-Swift E
    Cochrane Database Syst Rev; 2015; 2015(5):CD009652. PubMed ID: 26106751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heroin maintenance for chronic heroin dependents.
    Ferri M; Davoli M; Perucci CA
    Cochrane Database Syst Rev; 2003; (4):CD003410. PubMed ID: 14583974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heroin maintenance for chronic heroin dependents.
    Ferri M; Davoli M; Perucci CA
    Cochrane Database Syst Rev; 2003; (3):CD003410. PubMed ID: 12917967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detoxification treatments for opiate dependent adolescents.
    Minozzi S; Amato L; Bellisario C; Davoli M
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD006749. PubMed ID: 24777492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.